Mural Oncology plc Net Asset Quality Index
Mural Oncology plc net asset quality index. Mural Oncology plc (MURA) has a Net Asset Quality Index of 83.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $65.76 Million minus total liabilities of $10.57 Million yields net assets of $55.19 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Mural Oncology plc's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Mural Oncology plc (2021–2024)
Net asset quality index of Mural Oncology plc from 2021 to 2024. This chart shows how Mural Oncology plc's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 83.9%, representing net assets of $55.19 Million against total assets of $65.76 Million USD. Check how tangible is Mural Oncology plc's equity to evaluate the tangible quality of the company's equity base.
Mural Oncology plc Net Asset Quality Index by Year (2021–2024)
Mural Oncology plc net asset quality index by year from 2021 to 2024. The table below presents the year-by-year Net Asset Quality Index for Mural Oncology plc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Mural Oncology plc (MURA) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.9% | $140.50 Million | $169.39 Million | $28.89 Million | ▼ -4.5 pp |
| 2023 | 87.4% | $263.82 Million | $301.75 Million | $37.93 Million | ▲ +151.6 pp |
| 2022 | -64.2% | $-21.66 Million | $33.75 Million | $55.41 Million | ▼ -13.2 pp |
| 2021 | -50.9% | $-17.88 Million | $35.11 Million | $52.99 Million | — |